# Lisata Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 10-K/A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 16:03 ET
- Period: 2025-12-31
- Accession: 0000320017-26-000028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001726000028/clbs-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001726000028/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001726000028/clbs-20251231.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0000320017-26-000028. Last ingested by Listed: Nov 10, 2026, 04:21 ET. No prices; not investment advice.